British consumers’ appetite for home entertainment reached new heights in 2024, with the sector surpassing £5.1 billion ($6.4 ...

Amid the financial shock waves being sent by the release of DeepSeek's open source artificial intelligence R1 model, ...

Oppenheimer initiated coverage of Alumis (ALMS) with an Outperform rating and $32 price target The company is focused on delivering ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Christopher Nolan has recently announced his reunion with Oppenheimer star Benny Safdie for his next movie.Safdie, who appeared as physicist Edward Teller in Nolan’s Oscar-winning movie, ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.

Christopher Nolan to reunite with Oppenheimer actor for new movie - Nolan is following up Oppenheimer with an adaptation of ...

The stacked cast of Christopher Nolan's adaptation of Homer's Greek epic poem The Odyssey continues to grow with another ...

Apple Inc. was downgraded to perform from outperform at Oppenheimer, in the latest sign of caution building ahead of the ...

Christopher Nolan has added another star who appeared in Oppenheimer to his mythic adventure The Odyssey. Benny Safdie, who portrayed Edward Teller, recently joined the bandwagon, according to The ...

Oppenheimer upgraded Ovid Therapeutics (OVID) to Outperform from Perform with a $4 price target The firm says OV329’s promise is “quite real” ...

Peter Oppenheimer, the chief of global equity strategy and the head of macro research for Goldman Sachs in Europe, opined ...